Yongjun Wang
Impact in
- Health Informatics top 0.01%
- Artificial Intelligence in Healthcare and Education
- Epidemiology top 0.05%
- Acute Ischemic Stroke Management
- Autophagy in Disease and Therapy
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 306
- Acute Ischemic Stroke Management 280
-
- Antiplatelet Therapy and Cardiovascular Diseases 75
- Co-authors
- Hao Li (217 shared papers)Liping Liu (205 shared papers)Rajat Singh (7 shared papers)Xingquan Zhao (251 shared papers)Yilong Wang (172 shared papers)Youqing Xiang (5 shared papers)Yong Jiang (87 shared papers)David Wang (46 shared papers)
- Journals
- Stroke and Vascular Neurology (91 papers)Stroke (80 papers)Neurological Research (46 papers)Frontiers in Neurology (34 papers)Journal of the American Heart Association (30 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yongjun Wang
903 papers receiving 30.4k citations
Yongjun Wang's Hit Papers
Peers
Comparison fields: 5 of 210
- Health Informatics 1.2k
- Epidemiology 9.8k
- Internal Medicine 747
- Neurology 1.7k
- Rehabilitation 1.3k
Countries citing papers authored by Yongjun Wang
This map shows the geographic impact of Yongjun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongjun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongjun Wang more than expected).
Fields of papers citing papers by Yongjun Wang
This network shows the impact of papers produced by Yongjun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongjun Wang. The network helps show where Yongjun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yongjun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 959 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Autophagy regulates lipid metabolism Hit paper breakdown → | 2009 | 3248 |
| 2 | Artificial intelligence in healthcare: past, present and future Hit paper breakdown → | 2017 | 3016 |
| 3 | Prevalence, Incidence, and Mortality of Stroke in China Hit paper breakdown → | 2017 | 1504 |
| 4 | Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack Hit paper breakdown → | 2013 | 1147 |
| 5 | Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage Hit paper breakdown → | 2016 | 688 |
| 6 | Autophagy regulates adipose mass and differentiation in mice Hit paper breakdown → | 2009 | 645 |
| 7 | Stroke and Stroke Care in China Hit paper breakdown → | 2011 | 644 |
| 8 | China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations Hit paper breakdown → | 2020 | 347 |
| 9 | Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack Hit paper breakdown → | 2016 | 335 |
| 10 | 2005 | 334 | |
| 11 | Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA Hit paper breakdown → | 2020 | 326 |
| 12 | China cardiovascular diseases report 2018: an updated summary. Hit paper breakdown → | 2020 | 314 |
| 13 | 2016 | 258 | |
| 14 | China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations Hit paper breakdown → | 2022 | 253 |
| 15 | Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases Hit paper breakdown → | 2020 | 228 |
| 16 | 2014 | 222 | |
| 17 | 2011 | 209 | |
| 18 | 2016 | 206 | |
| 19 | 2016 | 196 | |
| 20 | 2019 | 195 |
About Yongjun Wang
Yongjun Wang is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Neurology and Surgery, having authored 959 papers that have together received 31.0k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (280 papers), Cerebrovascular and Carotid Artery Diseases (89 papers), Antiplatelet Therapy and Cardiovascular Diseases (75 papers), Intracerebral and Subarachnoid Hemorrhage Research (49 papers), Stroke Rehabilitation and Recovery (35 papers), Neurological Disease Mechanisms and Treatments (26 papers), Venous Thromboembolism Diagnosis and Management (22 papers) and Lipoproteins and Cardiovascular Health (19 papers). The work is most often cited by research in Health Informatics (1.2k citations), Epidemiology (9.8k citations), Internal Medicine (747 citations), Neurology (1.7k citations) and Rehabilitation (1.3k citations). Yongjun Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hao Li, Liping Liu, Rajat Singh, Xingquan Zhao, Yilong Wang, Youqing Xiang, Yong Jiang, David Wang, Mark J. Czaja and Ana María Cuervo. Their work appears in journals such as Stroke and Vascular Neurology, Stroke, Neurological Research, Frontiers in Neurology and Journal of the American Heart Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.